Oxford, UK - November 2009
As part of its DrugFinder initiative, InhibOx has undertaken a project in collaboration with the group of Dr. Angela Russell of the Chemistry Department, at the University of Oxford. Taking an oncology kinase target as its starting point, InhibOx performed virtual screening of its internal databases, using its proprietary software platform to identify potential inhibitors for experimental screening.
